Sigma Planning Corp’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.69M | Sell |
3,374
-54
| -2% | -$25.9K | 0.04% | 412 |
|
|
2026
Q1 | $1.68M | Sell |
3,428
-68
| -2% | -$36.9K | 0.05% | 383 |
|
|
2025
Q4 | $2.02M | Buy |
3,496
+179
| +5% | +$101K | 0.06% | 333 |
|
|
2025
Q3 | $1.61M | Sell |
3,317
-55
| -2% | -$25.6K | 0.05% | 380 |
|
|
2025
Q2 | $1.37M | Sell |
3,372
-617
| -15% | -$258K | 0.04% | 401 |
|
|
2025
Q1 | $1.99M | Buy |
3,989
+169
| +4% | +$91.5K | 0.06% | 284 |
|
|
2024
Q4 | $1.99M | Sell |
3,820
-272
| -7% | -$150K | 0.06% | 286 |
|
|
2024
Q3 | $2.53M | Sell |
4,092
-122
| -3% | -$72.2K | 0.08% | 240 |
|
|
2024
Q2 | $2.33M | Sell |
4,214
-385
| -8% | -$221K | 0.07% | 253 |
|
|
2024
Q1 | $2.67M | Buy |
4,599
+2,292
| +99% | +$1.29M | 0.08% | 238 |
|
|
2023
Q4 | $1.22M | Sell |
2,307
-3,033
| -57% | -$1.47M | 0.1% | 232 |
|
|
2023
Q3 | $2.7M | Sell |
5,340
-8
| -0.1% | -$4.26K | 0.1% | 210 |
|
|
2023
Q2 | $2.79M | Sell |
5,348
-1,463
| -21% | -$789K | 0.1% | 223 |
|
|
2023
Q1 | $3.93M | Buy |
6,811
+162
| +2% | +$91.3K | 0.13% | 167 |
|
|
2022
Q4 | $3.66M | Buy |
6,649
+172
| +3% | +$91.1K | 0.13% | 173 |
|
|
2022
Q3 | $3.29M | Buy |
6,477
+81
| +1% | +$45.3K | 0.13% | 177 |
|
|
2022
Q2 | $3.48M | Sell |
6,396
-105
| -2% | -$57.8K | 0.12% | 177 |
|
|
2022
Q1 | $3.84M | Buy |
6,501
+86
| +1% | +$49.4K | 0.12% | 187 |
|
|
2021
Q4 | $4.28M | Buy |
6,415
+8
| +0.1% | +$5K | 0.12% | 180 |
|
|
2021
Q3 | $3.66M | Sell |
6,407
-189
| -3% | -$104K | 0.11% | 200 |
|
|
2021
Q2 | $3.33M | Buy |
6,596
+229
| +4% | +$108K | 0.1% | 221 |
|
|
2021
Q1 | $2.91M | Buy |
6,367
+654
| +11% | +$312K | 0.09% | 246 |
|
|
2020
Q4 | $2.66M | Buy |
5,713
+333
| +6% | +$156K | 0.09% | 221 |
|
|
2020
Q3 | $2.38M | Buy |
5,380
+223
| +4% | +$92.1K | 0.09% | 218 |
|
|
2020
Q2 | $1.87M | Buy |
5,157
+589
| +13% | +$197K | 0.08% | 253 |
|
|
2020
Q1 | $1.3M | Sell |
4,568
-146
| -3% | -$46K | 0.08% | 270 |
|
|
2019
Q4 | $1.53M | Buy |
4,714
+732
| +18% | +$222K | 0.06% | 306 |
|
|
2019
Q3 | $1.16M | Sell |
3,982
-279
| -7% | -$79.9K | 0.06% | 338 |
|
|
2019
Q2 | $1.25M | Sell |
4,261
-190
| -4% | -$52.3K | 0.06% | 304 |
|
|
2019
Q1 | $1.22M | Buy |
4,451
+697
| +19% | +$173K | 0.07% | 274 |
|
|
2018
Q4 | $840K | Buy |
3,754
+368
| +11% | +$86.3K | 0.06% | 289 |
|
|
2018
Q3 | $827K | Buy |
3,386
+113
| +3% | +$26K | 0.05% | 341 |
|
|
2018
Q2 | $678K | Sell |
3,273
-68
| -2% | -$14.4K | 0.05% | 378 |
|
|
2018
Q1 | $690K | Buy |
3,341
+54
| +2% | +$11.3K | 0.05% | 347 |
|
|
2017
Q4 | $624K | Buy |
3,287
+1,355
| +70% | +$260K | 0.05% | 377 |
|
|
2017
Q3 | $366K | Buy |
+1,932
| New | +$350K | 0.03% | 534 |
|
Other funds holding TMO
Sigma Planning Corp's TMO Position: Q2 2026 in Review
Sigma Planning Corp reduced its Thermo Fisher Scientific (TMO) stake by 1.6% in Q2 2026, selling an estimated $25.9K and leaving 3,374 shares worth $1.69M. The position accounts for 0.04% of the portfolio, ranked #412.
Sigma Planning Corp first reported a position in TMO in Q3 2017 and has held it in 36 quarters since. The position peaked at $4.28M in Q4 2021. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Sigma Planning Corp held 3,374 shares of Thermo Fisher Scientific worth $1.69M as of Q2 2026.
- Sigma Planning Corp sold 54 Thermo Fisher Scientific shares in Q2 2026, an estimated $25.9K.
- Thermo Fisher Scientific made up 0.04% of Sigma Planning Corp's portfolio in Q2 2026, its #412 holding.
- Sigma Planning Corp first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 36 quarters since.
- Sigma Planning Corp's Thermo Fisher Scientific position peaked at $4.28M in Q4 2021.
- 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Sigma Planning Corp's 13F filing for Q2 2026, filed 7 Aug 2026.